ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
ENDRA Life Sciences's profit margin for the twelve months ending Dec 31, 2018 was -158669.6%. For fiscal 2018 it was -158669.6%, against -1529.2% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -158669.6% | −157140.4 |
| FY2017 | Dec 31, 2017 | -1529.2% | −990.9 |
| FY2016 | Dec 31, 2016 | -538.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2018 | Mar 31, 2018 | -45761.3% | −45627.7 |
| Q4 FY2017 | Dec 31, 2017 | -33498.4% | – |
| Q3 FY2017 | Sep 30, 2017 | -316.7% | – |
| Q2 FY2017 | Jun 30, 2017 | -2478.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -133.6% | – |
See a number that looks wrong?